trial

Virtual Reality and Artificial Intelligence in Treatment for Patients With Psychosis

NCTId NCT06728241
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 150 (estimated)
Sponsored by Oslo University Hospital
Primary completion 2027-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
150 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2024-12-06
Primary completion
2027-12-31
Eligibility
ALL · 17 Years · 65 Years

Interventions & indications

Drugs
RecoVRyVR Games

Sponsors

Oslo University HospitalLead Sponsor

Investigators

1
Jan I Røssberg, MD, PhDPrincipal Investigator

Sites

2 total
Oslo, NorwayNydalen, Norway

Facts & assertions

4 sourced
Enrollment
150
Phase
NA
Primary Completion Date
2027-12-31
Status
RECRUITING
relationships
The graph out of here
drug
RecoVRy
drug
VR Games
drug
lead_sponsor
Oslo University Hospital
company
indication
Psychosis
indication
Schizophrenia
indication
Anxiety Disorders
indication
investigator
Jan I Røssberg, MD, PhD
person